CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib-resistant chronic myeloid leukaemia-Reference-Cited by-同舟云学术

CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib-resistant chronic myeloid leukaemia

Published:2015-06-04 Issue:1 Volume:237 Page:14-24
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Gioia Romain¹,Trégoat Claire¹,Dumas Pierre-Yves¹,Lagarde Valérie¹,Prouzet-Mauléon Valérie¹,Desplat Vanessa¹,Sirvent Audrey²,Praloran Vincent¹,Lippert Eric¹,Villacreces Arnaud¹,Leconet Wilhem³,Robert Bruno³,Vigon Isabelle¹,Roche Serge²,Mahon François-Xavier¹,Pasquet Jean-Max¹

Affiliation:

1. Hématopoïèse Leucémique et Cibles Thérapeutiques; INSERM U1035; Université de Bordeaux France

2. CNRS UMR5237; Centre de Recherche de Biochimie Macromoléculaire; Montpellier France

3. Equipe Immunociblage et Radiobiologie en Oncologie; IRCM Institut de Recherche en Cancérologie de Montpellier; INSERM U896-Université Montpellier1-ICM Montpellier France

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/path.4561/fullpdf

Reference33 articles.

1. Chromosome abnormalities in malignant hematologic diseases;Rowley;Adv Cancer Res,1982

2. Oncogene activation by chromosomal translocation in chronic myelocytic leukemia;Groffen;Cold Spring Harb Symp Quant Biol,1986

3. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype;Melo;Blood,1996

4. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome;Daley;Science,1990

5. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products;Lugo;Science,1990

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LINC00926 promotes progression of renal cell carcinoma via regulating miR-30a-5p/SOX4 axis and activating IFNγ-JAK2-STAT1 pathway;Cancer Letters;2023-12

2. Inhibition of a new AXL isoform, AXL3, induces apoptosis of mantle cell lymphoma cells;Blood;2023-10-26

3. Exploiting the potential of the ubiquitin-proteasome system in overcoming tyrosine kinase inhibitor resistance in chronic myeloid leukemia;Genes & Diseases;2023-10

4. BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia;Pharmaceutics;2022-01-17

5. The Role of AXL Receptor Tyrosine Kinase in Cancer Cell Plasticity and Therapy Resistance;Biomarkers of the Tumor Microenvironment;2022